Glycine

Glycine

SCHEMBL28463137

NCC(=O)O.O=C(O)CC(NC(CC(=O)O)C(=O)O)C(=O)O

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D

The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GLRA1 P23415 1/20 0.48
▸ SLC6A9 P48067 1/20 0.48
▸ OR51E2 Q9H255 1/20 0.48
▸ CA2 P00918 3/20 0.42
▸ CA4 P22748 1/20 0.42
▸ GABRR1 P24046 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.40
▸ TGFBR1 P36897 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GNPAT O15228 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ MME P08473 2/20 0.37
▸ SLC22A6 Q4U2R8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylenediamine SCHEMBL20954155 0.91 CA2 (0.42) CA2CA4GABRR1LMNATDP1
Hydroxyamine SCHEMBL631500 0.90 CA2 (0.45) CA2CA4GABRR1LMNATDP1
SCHEMBL1457564 0.90 CA2 (0.48) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL22019 0.90 CA2 (0.48) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL2916092 0.90 CA2 (0.48) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL2910640 0.90 CA2 (0.48) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL3055923 0.87 CA2 (0.47) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL18419474 0.87 CA2 (0.47) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL5327417 0.87 CA2 (0.47) CA2CA4TDP1TGFBR1SMN1; SMN2
SCHEMBL1419353 0.87 CA2 (0.47) CA2CA4TDP1TGFBR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117871219-A Dyeing liquid for urine tangible analysis and use method thereof 迪瑞医疗科技股份有限公司 2024-04-12 — — CN claimed
CN-114959708-A Etching liquid composition 易安爱富科技有限公司 2022-08-30 — — CN claimed
CN-111690932-A Etching solution composition for silver-containing metal film 易安爱富科技有限公司 2020-09-22 — — CN claimed
CN-117871219-A Dyeing liquid for urine tangible analysis and use method thereof 迪瑞医疗科技股份有限公司 2024-04-12 — — CN disclosed
CN-111690932-A Etching solution composition for silver-containing metal film 易安爱富科技有限公司 2020-09-22 — — CN disclosed
Send feedback